Abstract
N-methyl-D-aspartate (NMDA) receptor plays important roles in learning and memory. NMDA receptors are a tetramer that consists of two glycine-binding subunits GluN1, two glutamate-binding subunits (i.e., GluN2A, GluN2B, GluN2C, and GluN2D), a combination of a GluN2 subunit and glycine-binding GluN3 subunit (i.e., GluN3A or GluN3B), or two GluN3 subunits. Recent studies revealed that the specific expression and distribution of each subunit are deeply involved in neural excitability, plasticity, and synaptic deficits. The present article summarizes reports on the dysfunction of NMDA receptors and responsible subunits in various neurological and psychiatric disorders, including schizophrenia, autoimmune-induced glutamatergic receptor dysfunction, mood disorders, and autism. A key role for the GluN2D subunit in NMDA receptor antagonist-induced psychosis has been recently revealed.
Keywords: GluN1, GluN2D, knockout mice, NMDA receptor subtype, phencyclidine, psychiatric disorders.
Current Molecular Medicine
Title:Specific Roles of NMDA Receptor Subunits in Mental Disorders
Volume: 15 Issue: 3
Author(s): H. Yamamoto, Y. Hagino, S. Kasai and K. Ikeda
Affiliation:
Keywords: GluN1, GluN2D, knockout mice, NMDA receptor subtype, phencyclidine, psychiatric disorders.
Abstract: N-methyl-D-aspartate (NMDA) receptor plays important roles in learning and memory. NMDA receptors are a tetramer that consists of two glycine-binding subunits GluN1, two glutamate-binding subunits (i.e., GluN2A, GluN2B, GluN2C, and GluN2D), a combination of a GluN2 subunit and glycine-binding GluN3 subunit (i.e., GluN3A or GluN3B), or two GluN3 subunits. Recent studies revealed that the specific expression and distribution of each subunit are deeply involved in neural excitability, plasticity, and synaptic deficits. The present article summarizes reports on the dysfunction of NMDA receptors and responsible subunits in various neurological and psychiatric disorders, including schizophrenia, autoimmune-induced glutamatergic receptor dysfunction, mood disorders, and autism. A key role for the GluN2D subunit in NMDA receptor antagonist-induced psychosis has been recently revealed.
Export Options
About this article
Cite this article as:
Yamamoto H., Hagino Y., Kasai S. and Ikeda K., Specific Roles of NMDA Receptor Subunits in Mental Disorders, Current Molecular Medicine 2015; 15 (3) . https://dx.doi.org/10.2174/1566524015666150330142807
DOI https://dx.doi.org/10.2174/1566524015666150330142807 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial [ NeuroAIDS: A Neuroscience Problem with Global Impact ]
Current HIV Research Immune Checkpoint Inhibitors and Neurotoxicity
Current Neuropharmacology Immune Response to Herpes Simplex Virus and γ134.5 Deleted HSV Vectors
Current Gene Therapy Invasion and Egress by the Obligate Intracellular Parasite Toxoplasma gondii: Potential Targets for the Development of New Antiparasitic Drugs
Current Pharmaceutical Design Alzheimers Disease and P300: Review and Evaluation of Task and Modality
Current Alzheimer Research The Infectious Etiology of Alzheimer’s Disease
Current Neuropharmacology Inflammation and Innate Immune Response Against Viral Infections in Marine Fish
Current Pharmaceutical Design LRP/LR as an Alternative Promising Target in Therapy of Prion Diseases, Alzheimers Disease and Cancer
Infectious Disorders - Drug Targets HIV-1: The Confounding Variables of Virus Neutralization
Current Drug Targets - Infectious Disorders Innate Immunity and Vaccines
Current Topics in Medicinal Chemistry Neurotrophic Factors in the Pathogenesis of Neurological Disorders with Mental Retardation in Children
Current Pediatric Reviews Pseudotyping Viral Vectors With Emerging Virus Envelope Proteins
Current Gene Therapy Kynurenine System and Multiple Sclerosis, Pathomechanism and Drug Targets with An Emphasis on Laquinimod
Current Drug Targets Leptinaemia and Antiendothelial Antibodies in Accelerated Atherosclerosis – Is There a Relationship?
Vascular Disease Prevention (Discontinued) Metal and Inflammatory Targets for Alzheimers Disease
Current Drug Targets A Review on Clinical Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Natalizumab: A Humanized Anti-α4 Integrin Monoclonal Antibody
Current Drug Metabolism T2/FLAIR Hyperintensity in Mesial Temporal Lobe: Challenging Differential Diagnosis
Current Medical Imaging Regulation of Innate Immune Responses in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Playing with Fire: Manipulation of Macrophage Proinflammatory Signal Transduction by the Intracellular Protozoan Toxoplasma gondii
Current Immunology Reviews (Discontinued) The Host Complement System and Arbovirus Pathogenesis
Current Drug Targets